pubmed-article:15033256 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15033256 | lifeskim:mentions | umls-concept:C0020542 | lld:lifeskim |
pubmed-article:15033256 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15033256 | lifeskim:mentions | umls-concept:C0529793 | lld:lifeskim |
pubmed-article:15033256 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:15033256 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:15033256 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:15033256 | pubmed:dateCreated | 2004-3-22 | lld:pubmed |
pubmed-article:15033256 | pubmed:abstractText | The treatment of patients with pulmonary arterial hypertension remains a challenge. We set out to investigate the use of sildenafil, a selective inhibitor of phosphodiesterase type 5, in patients with this disease. | lld:pubmed |
pubmed-article:15033256 | pubmed:language | eng | lld:pubmed |
pubmed-article:15033256 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15033256 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15033256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15033256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15033256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15033256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15033256 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15033256 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15033256 | pubmed:month | Mar | lld:pubmed |
pubmed-article:15033256 | pubmed:issn | 0195-668X | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:FuY PYP | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:ChesterAdrian... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:YacoubMagdi... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:MitchellAndre... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:StephensDavid... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:KhanMohammedM | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:EvansTimothy... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:RogersPaulaP | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:GatzoulisMich... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:GibbsJ S RJS | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:PrasadSanjay... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:BayneStephani... | lld:pubmed |
pubmed-article:15033256 | pubmed:author | pubmed-author:MikhailGhada... | lld:pubmed |
pubmed-article:15033256 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15033256 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:15033256 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15033256 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15033256 | pubmed:pagination | 431-6 | lld:pubmed |
pubmed-article:15033256 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:meshHeading | pubmed-meshheading:15033256... | lld:pubmed |
pubmed-article:15033256 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15033256 | pubmed:articleTitle | Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. | lld:pubmed |
pubmed-article:15033256 | pubmed:affiliation | Adult Congenital Heart Unit, Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP UK. | lld:pubmed |
pubmed-article:15033256 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15033256 | lld:pubmed |